myNEO Company
myNEO engages in the research, development, and optimization of the clinical exploitability of personalized cancer immunotherapy.
Headquarters:
Ghent, Oost-Vlaanderen, Belgium
Industry:
Preclinical Development
Founded Date:
2018-01-01